Lataa...
Budesonide induces complete remission in autoimmune hepatitis
AIM: Prednisone and azathioprine represent the standard treatment for autoimmune hepatitis (AIH). However, only 65% of the patients enter complete histological remission. Recently, budesonide (BUD) was reported to be a promising alternative. In this study we assessed the efficacy and safety of BUD i...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Co., Limited
2006
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4124311/ https://ncbi.nlm.nih.gov/pubmed/16552802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i9.1362 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|